Articles

Countdown to Cali-serialization

ePedigree & Serialization: What you need to know NOW for the California 2015 deadline
Post Date: 02/15/2013
Author: William McLaury, Head, Pharma Supply Chain Strategy, Novartis Pharmaceuticals...

Strength in Unity: The Case for Global Supply Chain Standards

Agreement around common supply chain standards and supporting processes could revolutionize the healthcare sector
Post Date: 02/01/2013
Author: Thomas Ebel, Katy George, Erik Larsen, and Ketan Shah

Vision System Helps to Increase the OEE on Pharma Packaging Line by 200%

The approach reduced the false reject rate to 0.5%, improving the first pass yield consequently the overall equipment effectiveness.
Post Date: 07/18/2012
Author:

Track and Trace Gains Prominence in the War Against Counterfeit Drugs

Regulation and technology lead the fight against counterfeit pharmaceuticals.
Post Date: 03/14/2012
Author: Franz Ludwig, Bosch Packaging Technology

Split Decisions: Tablet Scoring Under More Scrutiny

FDA provides more direction as questions arise about dosage consistency.
Post Date: 01/11/2012
Author: Paul Thomas, Senior Editor

Serialization & Traceability: Where Pharma Stands

A new survey sheds light upon choices and challenges.
Post Date: 06/27/2011
Author: Paul Thomas, Senior Editor

2011: Progress on the Pedigree Front?

Maxiom Group’s Scott Dicks answers our questions about whether drug manufacturers are moving ahead with electronic pedigree programs.
Post Date: 03/09/2011
Author: Paul Thomas, Senior Editor

Can Drug Manufacturers Find Business Benefits in Product Serialization?

John Danese, Oracle’s Director of Product Strategy, provides an update on the electronic pedigree landscape and how manufacturers are doing in their serialization efforts.
Post Date: 03/09/2011
Author: Paul Thomas, Senior Editor

Pedigree Adopters Play the Waiting Game

Manufacturers’ electronic pedigree and serialization efforts creep ahead, slowed by FDA’s inaction.
Post Date: 03/09/2011
Author: Paul Thomas, Senior Editor

RFID Makes a Slight Comeback: Implications for the Life Sciences Supply Chain


Post Date: 02/16/2011
Author:

Therapeutic Dose: Sympathizing with da Vinci

Like Leonardo, we’ve got great technologies, just not the infrastructure and support for them.
Post Date: 12/06/2010
Author: Emil Ciurczak, Contributing Editor

Retooling for Traceability: 10 Steps

There’s more to serialization than generating numbers and printing them on a label.
Post Date: 12/06/2010
Author: Josh Capogna, McRae Integration and John Lewis, Cognex Corporation

How New Packaging Technologies are Helping in the Struggle Against Counterfeit Drugs

This article discusses counterfeit drugs, current regulations and the latest packaging technologies.
Post Date: 08/23/2010
Author: Richard Burhouse, Business Development Manager, Payne Security

Supplier Audits: Drawing ROI from a Trusted Community

If supplier audits could be harmonized and shared amongst trusted partners, "we could effectively revolutionize the entire industry" and make our supply chains much safer, says Sigma-Aldrich's Tom Beil.
Post Date: 06/10/2010
Author: Paul Thomas, Senior Editor

Webinar: Tackling Counterfeit Drugs with Serialization
This Oracle and PRISYM ID Webinar examines how serialization helps defend against counterfeiting: using labeling and management solutions to deliver secure and compliant printing for mass serialization, enhancing existing equipment and production lines to cope with changes, and tracking products through the supply ...
Post Date: 04/29/2010
Author: PRISYM ID

PDA 2010: Stopper Sensibility

At PDA 2010, lyophilization experts debate issues that confound them and compromise product and vial integrity.
Post Date: 03/23/2010
Author: Paul Thomas, Senior Editor

The Path to Epedigree: Manufacturers Chart Their Course

During a legislative lull, drug manufacturers muster up momentum to implement electronic pedigree programs.
Post Date: 03/04/2010
Author: Paul Thomas, Senior Editor

ePedigree: The Rugged Road Ahead

Don't be fooled by the recent lull in electronic pedigree chatter; it's just the calm before the storm, and manufacturers need to be considering pedigree within their broader brand protection programs, says Oracle's John Danese, director of life sciences product strategy for Oracle.
Post Date: 03/04/2010
Author:

Taking the Plunge to Harmonize Pharmaceutical Regulations

Within the past five years, more of world's regulatory agencies and pharmacopeias have gotten on the same wavelength.
Post Date: 03/04/2010
Author: Agnes Shanley, Editor in Chief

Getting More Scientific About Tableting

Last month brought news of resources and newer techniques being brought to bear on tableting.
Post Date: 02/23/2010
Author: